Dear Colleague,

Are you attending the 2019 BIO International Convention next month? Join FierceBiotech for an Executive Breakfast on June 5th from 6:45AM-8:30AM. This year's panel topic is Getting Real: The Changing Tide on Real-World Evidence on Drug Development.

Attendees will have the opportunity to hear from industry experts including:

• Jennifer Graff, PharmD / Vice President of Comparative Effectiveness Research / National Pharmaceutical Council
• Jack Sheehan, RPh, MBA, PhD / Director, Real-World Value and Evidence, Neuroscience / Janssen Scientific Affairs (JSA)
• Danny Wiederkehr / Senior Director, Global Health Economics and Outcomes Research Team Lead / Pfizer
• William Yoon / Executive Director and Head, US Medical Account Management and Strategic Alliances / Sandoz

The panel will focus on the drugmakers that are running real-world studies to find and tap new marketing and payer insights, including long-term safety and outcomes. This new approach requires significant investment and real-world evidence requires the right talent and technology. Our industry expert panelists will address the important questions that companies are facing including where to find that talent & technology and how to deploy it internally or with partners.

Register now to secure your spot at low early bird rates through this Friday, May 10th. You do not have to be registered for the BIO International Convention to attend this breakfast event - all are welcome.

I look forward to seeing you soon in Philadelphia.

Regards,

Rebecca Willumson
Publisher
FierceBiotech